Testing LISA breathing treatment for very preterm newborns
Treatments studied
Part of Lungs & breathing clinical trials.
This trial is studying whether giving a lung “surfactant” medicine through a thin tube (called LISA) helps very premature babies with breathing problems. It aims to see if this approach improves care for babies born around 24 to 30 weeks gestation who still need oxygen support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born at one of the trial hospitals (trial sites).
- Your baby’s gestational age at birth must be between 24 weeks 0 days and 29 weeks 6 days.
- Your baby must have breathing trouble (RDS) and be on CPAP with a pressure of at least 6 cm H2O, with oxygen needs (FiO2) greater than 0.30.
- Before starting the LISA treatment, there must not be concerns for underdeveloped lungs (lung hypoplasia).
- Your baby must not have been intubated (given a breathing tube) at any time before randomization.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving surfactant (a substance that helps lungs stay open) to premature babies with Respiratory Distress Syndrome (RDS) through a mask on the throat (supraglottic airway) is safe and effective. It may be an option for babies who need extra oxygen but are not on a breathing tube.
This trial uses a lung ultrasound score, a type of ultrasound, to decide when to give surfactant (a medicine that helps lungs work) to premature babies born between 27 and 35 weeks of pregnancy. It aims to reduce the need for more breathing support and avoid side effects.
This trial tests a breathing support method called CPAP for premature babies with breathing problems in Africa. It may help your baby get better oxygen and avoid more invasive treatments.
This study compares two ways of giving surfactant (a lung-coating medicine) to newborns with breathing trouble: LISA (a gentler, less invasive method) versus traditional breathing tube delivery. Researchers will use ultrasound to see how the medicine spreads in each baby's lungs to find the best approach.
This study tests whether giving a pre-medication before a less invasive lung treatment (surfactant) improves breathing in premature babies. It may help some babies avoid more invasive ventilation while still getting the lung medication they need.
This trial tests a less invasive way to give surfactant (a lung treatment) to babies born a few weeks early who need breathing help. It aims to see if this method works as well as standard care.
Hear when a new Respiratory Distress Syndrome in Premature Infant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.